Furthermore, the overlap of EGF and IGF-2 pathways, as demonstrated by merging both networks into a single pathway, could enable IGF-2 to take over the functional role of EGF and thus render the tumor cell independent of EGF signaling. The gene discussed is IGF2; the disease is neoplasm.